Humira Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials
• Forums

Hulio Interchangeability to Humira ®, Comparing Pharmacokinetics, Efficacy, Safety and Immunogenicity
Condition:   Moderate to Severe Chronic Plaque Psoriasis Interventions:   Biological: Humira 40 MG in Prefilled Syringe;   Biological: Hulio 40 MG in Prefilled Syringe / Humira 40 MG in Prefilled Syringe Sponsors:   Mylan Pharmaceuticals Inc;   Mylan Inc.;   MEDA Pharma GmbH & Co. KG;   IQVIA Pvt. Ltd Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2022 Category: Research Source Type: clinical trials

Observational Study, to Assess Treatment Retention of an Adalimumab Biosimilar (Hyrimoz ®) in IBD Patients in Real Life Setting
Condition:   Inflammatory Bowel Disease Intervention:   Other: Hyrimoz Sponsor:   Sandoz Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 1, 2022 Category: Research Source Type: clinical trials